Relationships forged amidst the glitz and glamour of Las Vegas have a reputation for ending badly; the one between the University of Nevada, Reno (UNR), and the Lou Ruvo Brain Institute (LRBI) was apparently no exception...
At a satellite symposium, “Nicotinic Acetylcholine Receptors (nAChRs) as Therapeutic Targets,” clinical discussion of cognitive treatments focused largely on nAChR agonists...
Days before the masses swarmed to the SfN annual meeting, a more intimate assembly of 287 exchanged the latest buzz on nicotinic acetylcholine receptors...
In Alzheimer disease research, focus has recently shifted away from large plaques and toward small oligomers of amyloid as a potential cause of disease...
St. Louis: Scientists, Families Target Preclinical Detection, Trials St. Louis: The Family View—What Do Study Volunteers Want From DIAN? St. Louis: Cognition Pre-dementia—Like eFAD, Like LOAD? St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD? St. L
At the 7th Leonard Berg Symposium, brain imaging researchers of various stripes took stock of what brain imaging tells the field about the preclinical period of Alzheimer disease...
One question that pervaded the 7th Leonard Berg Symposium is whether dominantly inherited Alzheimer disease really is the same disease as the common late-onset forms...
Researchers have almost completely banished microglia from the brains of APP transgenic mice, and to their surprise they found absolutely no change in plaque size or number...
As throughout this conference, talks toggled between what’s known in LOAD and eFAD, comparing all the while how well knowledge on these forms of AD matches up...
At the 7th Leonard Berg Symposium scientists and patient advocates came together to exchange the latest news on detecting disease presymptomatically...
When do researchers get to hear from study participants how deeply their families have struggled for decades and what kinds of services would make studies worth their while?...